Virax Biolabs Group VRAX

Health care sectorNasdaq

Company

Exchange: Nasdaq
Sector: Health care
Industry: In Vitro & In Vivo Diagnostic Substances
Headquarters: Lanarkshire
Fiscal year end: 03/31

Korean holdings rank: Outside the top 50; Korea Securities Depository · released 09/22
Congress trades: No record; Last 90 days · 0 buys · 0 sales
Insider net buying: No record; Last 90 days · 0 buys · 0 sales
Next earnings: No record; Estimated from the last four quarters

26-week trading